Buchumschlag

Recurrent pseudoprogression in isocitrate dehydrogenase 1 mutant glioblastoma

In a subset of glioblastoma (GBM) patients, the differentiation between tumor progression and tumor pseudoprogression (PsP) is challenging. This case describes a male patient suffering from isocitrate dehydrogenase 1 (IDH1) mutant GBM who demonstrated an increasing contrast-enhancing (CE) lesion on...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Kebir, Sied (VerfasserIn) , Giordano, Frank Anton (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: July 2018
In: Journal of clinical neuroscience
Year: 2018, Jahrgang: 53, Pages: 255-258
ISSN:1532-2653
DOI:10.1016/j.jocn.2018.04.056
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.jocn.2018.04.056
Verlag, lizenzpflichtig, Volltext: http://www.sciencedirect.com/science/article/pii/S0967586818303345
Volltext
Verfasserangaben:Sied Kebir, Laurèl Rauschenbach, Gerrit H. Gielen, Niklas Schäfer, Theophilos Tzaridis, Björn Scheffler, Frank A. Giordano, Lazaros Lazaridis, Ulrich Herrlinger, Martin Glas

MARC

LEADER 00000caa a2200000 c 4500
001 1736230255
003 DE-627
005 20220818234705.0
007 cr uuu---uuuuu
008 201022s2018 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.jocn.2018.04.056  |2 doi 
035 |a (DE-627)1736230255 
035 |a (DE-599)KXP1736230255 
035 |a (OCoLC)1341373219 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Kebir, Sied  |e VerfasserIn  |0 (DE-588)1035782421  |0 (DE-627)749559985  |0 (DE-576)383535506  |4 aut 
245 1 0 |a Recurrent pseudoprogression in isocitrate dehydrogenase 1 mutant glioblastoma  |c Sied Kebir, Laurèl Rauschenbach, Gerrit H. Gielen, Niklas Schäfer, Theophilos Tzaridis, Björn Scheffler, Frank A. Giordano, Lazaros Lazaridis, Ulrich Herrlinger, Martin Glas 
264 1 |c July 2018 
300 |a 4 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 22.10.2020 
520 |a In a subset of glioblastoma (GBM) patients, the differentiation between tumor progression and tumor pseudoprogression (PsP) is challenging. This case describes a male patient suffering from isocitrate dehydrogenase 1 (IDH1) mutant GBM who demonstrated an increasing contrast-enhancing (CE) lesion on a cranial magnetic resonance imaging (cMRI) scan 8months after radiochemotherapy. In accordance with the response assessment in neuro-oncology (RANO) criteria, the cMRI lesion was classified as recurrent tumor, although 18F-fluoroethyl-L-tyrosine positron emission tomography (18F-FET-PET) did not indicate vital tumor tissue. The patient underwent re-surgery but histopathology only revealed reactive and necrotic tissue, consistent with PsP. Nine weeks after complete resection of the CE lesion, a new lesion emerged that later regressed in the follow-up cMRI scans, thereby retrospectively establishing the diagnosis of recurrent PsP. 
650 4 |a F-FET-PET 
650 4 |a Pseudoprogression 
650 4 |a RANO 
650 4 |a Recurrent pseudoprogression 
700 1 |a Giordano, Frank Anton  |d 1980-  |e VerfasserIn  |0 (DE-588)136378455  |0 (DE-627)694333093  |0 (DE-576)300990529  |4 aut 
773 0 8 |i Enthalten in  |t Journal of clinical neuroscience  |d Burlington, Mass. : Harcourt, 1994  |g 53(2018), Seite 255-258  |h Online-Ressource  |w (DE-627)320476235  |w (DE-600)2009190-4  |w (DE-576)264627431  |x 1532-2653  |7 nnas  |a Recurrent pseudoprogression in isocitrate dehydrogenase 1 mutant glioblastoma 
773 1 8 |g volume:53  |g year:2018  |g pages:255-258  |g extent:4  |a Recurrent pseudoprogression in isocitrate dehydrogenase 1 mutant glioblastoma 
856 4 0 |u https://doi.org/10.1016/j.jocn.2018.04.056  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u http://www.sciencedirect.com/science/article/pii/S0967586818303345  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20201022 
993 |a Article 
994 |a 2018 
998 |g 136378455  |a Giordano, Frank Anton  |m 136378455:Giordano, Frank Anton  |d 60000  |d 63000  |e 60000PG136378455  |e 63000PG136378455  |k 0/60000/  |k 1/60000/63000/  |p 7 
999 |a KXP-PPN1736230255  |e 3784402739 
BIB |a Y 
SER |a journal 
JSO |a {"title":[{"title_sort":"Recurrent pseudoprogression in isocitrate dehydrogenase 1 mutant glioblastoma","title":"Recurrent pseudoprogression in isocitrate dehydrogenase 1 mutant glioblastoma"}],"name":{"displayForm":["Sied Kebir, Laurèl Rauschenbach, Gerrit H. Gielen, Niklas Schäfer, Theophilos Tzaridis, Björn Scheffler, Frank A. Giordano, Lazaros Lazaridis, Ulrich Herrlinger, Martin Glas"]},"language":["eng"],"note":["Gesehen am 22.10.2020"],"person":[{"given":"Sied","role":"aut","roleDisplay":"VerfasserIn","family":"Kebir","display":"Kebir, Sied"},{"given":"Frank Anton","display":"Giordano, Frank Anton","family":"Giordano","roleDisplay":"VerfasserIn","role":"aut"}],"relHost":[{"title":[{"title_sort":"Journal of clinical neuroscience","title":"Journal of clinical neuroscience"}],"language":["eng"],"disp":"Recurrent pseudoprogression in isocitrate dehydrogenase 1 mutant glioblastomaJournal of clinical neuroscience","id":{"issn":["1532-2653"],"zdb":["2009190-4"],"eki":["320476235"]},"recId":"320476235","note":["Ungezählte Beil. ersch. als \"A\"-Nr. zusätzlich zur H.-Zählung"],"origin":[{"publisherPlace":"Burlington, Mass.","publisher":"Harcourt","dateIssuedKey":"1994","dateIssuedDisp":"1994-"}],"physDesc":[{"extent":"Online-Ressource"}],"part":{"text":"53(2018), Seite 255-258","year":"2018","extent":"4","volume":"53","pages":"255-258"},"type":{"bibl":"periodical","media":"Online-Ressource"},"pubHistory":["1.1994 -"]}],"recId":"1736230255","id":{"doi":["10.1016/j.jocn.2018.04.056"],"eki":["1736230255"]},"physDesc":[{"extent":"4 S."}],"origin":[{"dateIssuedDisp":"July 2018","dateIssuedKey":"2018"}],"type":{"media":"Online-Ressource","bibl":"article-journal"}} 
SRT |a KEBIRSIEDGRECURRENTP2018 

Ähnliche Einträge